Skip to main content
. 2021 Oct 9;43(12):3875–3887. doi: 10.1002/hed.26885

FIGURE 3.

FIGURE 3

Clinical course of patients with locoregional rHNSCC treated with RM‐1929 photoimmunotherapy: Patient 1 with recurrent left facial cancer; Patient 2 with bilateral intraoral recurrent tumors and neck dermal metastases; and Patient 3 with a tongue tumor